Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bio Essence (BIOE) Accumulated Depreciation & Amortization (2020 - 2024)

Bio Essence has reported Accumulated Depreciation & Amortization over the past 5 years, most recently at -$35769.0 for Q1 2024.

  • For Q1 2024, Accumulated Depreciation & Amortization fell 318.88% year-over-year to -$35769.0; the TTM value through Mar 2024 reached -$35769.0, down 318.88%, while the annual FY2023 figure was $56431.0, 5.0% up from the prior year.
  • Accumulated Depreciation & Amortization for Q1 2024 was -$35769.0 at Bio Essence, down from $56431.0 in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $229612.0 in Q3 2023 and troughed at -$35769.0 in Q1 2024.
  • A 5-year average of $52253.6 and a median of $25856.5 in 2021 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 1407.43% in 2023 and later crashed 318.88% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $135507.0 in 2020, then crashed by 78.26% to $29453.0 in 2021, then skyrocketed by 82.47% to $53742.0 in 2022, then increased by 5.0% to $56431.0 in 2023, then tumbled by 163.39% to -$35769.0 in 2024.
  • Business Quant data shows Accumulated Depreciation & Amortization for BIOE at -$35769.0 in Q1 2024, $56431.0 in Q4 2023, and $229612.0 in Q3 2023.